Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.cardfail.2007.03.010
DC FieldValue
dc.titleHeart Failure Mortality in Southeast Asian Patients With Left Ventricular Systolic Dysfunction
dc.contributor.authorSeow, S.-C.
dc.contributor.authorChai, P.
dc.contributor.authorLee, Y.-P.
dc.contributor.authorChan, Y.-H.
dc.contributor.authorKwok, B.W.K.
dc.contributor.authorYeo, T.-C.
dc.contributor.authorChia, B.-L.
dc.date.accessioned2016-12-19T06:49:53Z
dc.date.available2016-12-19T06:49:53Z
dc.date.issued2007-08
dc.identifier.citationSeow, S.-C., Chai, P., Lee, Y.-P., Chan, Y.-H., Kwok, B.W.K., Yeo, T.-C., Chia, B.-L. (2007-08). Heart Failure Mortality in Southeast Asian Patients With Left Ventricular Systolic Dysfunction. Journal of Cardiac Failure 13 (6) : 476-481. ScholarBank@NUS Repository. https://doi.org/10.1016/j.cardfail.2007.03.010
dc.identifier.issn10719164
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/133353
dc.description.abstractBackground: Prognostic indicators and mortality in multiethnic Southeast Asian patients with heart failure (HF) may be different. Methods and Results: The study population comprised 225 inpatients with HF with a left ventricular ejection fraction of 40% or less who were discharged alive. Five years later, survival and causes of death were determined. Proportionally, more Malay and Indian patients were admitted compared with Chinese patients (P < .001). There were 55.6% in New York Heart Association (NYHA) class III or IV. Ischemic heart disease was the most common cause (85.8%). At 5 years, 152 patients (67.5%) had died. Angiotensin-converting enzyme inhibitors were prescribed to 79.1% of patients on discharge. Cardiovascular causes accounted for 69.7% of deaths. Predictors of mortality include female gender (P = .046), age 70 years or more (P = .017), renal impairment (P = .008), NYHA class III or IV (P = .03), and non-use of angiotensin-converting enzyme inhibitors (P = .005). On multivariate analysis, increasing age (P = .001) and renal impairment (P = .019) were independent predictors of all-cause mortality. Cardiovascular death was more likely with NYHA class III or IV (P = .004) and renal impairment (P = .012). Conclusion: Mortality is unusually high in this group of patients despite treatment. Greater use of evidence-based therapies in HF-management programs may arrest this trend. © 2007 Elsevier Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.cardfail.2007.03.010
dc.sourceScopus
dc.subjectHeart failure
dc.subjectMortality
dc.subjectPredictors
dc.subjectPrognosis
dc.subjectSoutheast Asian
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1016/j.cardfail.2007.03.010
dc.description.sourcetitleJournal of Cardiac Failure
dc.description.volume13
dc.description.issue6
dc.description.page476-481
dc.description.codenJCFAF
dc.identifier.isiut000257502300009
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

14
checked on Dec 3, 2021

WEB OF SCIENCETM
Citations

15
checked on Nov 26, 2021

Page view(s)

84
checked on Dec 2, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.